SOFZIA
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90235145
- Registration number
- 6775781
- Mark type
- Design + words
- Filed
- 05 Oct 2020
- Published for opposition
- 26 Jan 2021
- Registered
- 28 Jun 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Preservative sold as an integral component of an ophthalmic pharmaceutical preparation for the treatment of glaucoma
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 25 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Apr 2022 — USE AMENDMENT FILED
- 28 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Apr 2022 — TEAS STATEMENT OF USE RECEIVED
- 23 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2022 — SOU EXTENSION 2 GRANTED
- 21 Mar 2022 — SOU EXTENSION 2 FILED
- 21 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Sept 2021 — SOU EXTENSION 1 GRANTED
- 20 Sept 2021 — SOU EXTENSION 1 FILED